Market Cap | ₹124Cr |
ROE | 13.86% |
P/E Ratio(TTM) | 10.79 |
EPS(TTM) | 10.03 |
P/B Ratio | 1.50 |
Dividend Yield | 0.00% |
Industry P/E | 36.00 |
Book Value | 72.35 |
Debt to Equity | 0.84 |
Face Value | 10 |
Parent Organisation | Parnax Lab Limited |
Managing Director | Mr. Baiju Shah |
BSE Symbol | 506128 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Torrent Pharmaceuticals | NA (0.00%) | 61.31 | ||
Ajanta Pharma | NA (0.00%) | 37.82 | ||
Gland Pharma | NA (0.00%) | 46.48 | ||
Eris Lifesciences | NA (0.00%) | 68.64 |